Hims & Hers Health Inc (NYSE: HIMS) is 28.41% higher on its value in year-to-date trading and has touched a low of $11.20 and a high of $72.98 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HIMS stock was last observed hovering at around $29.55 in the last trading session, with the day’s gains setting it 1.5%.
Currently trading at $31.05, the stock is -8.16% and -21.05% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 45.9 million and changing 5.08% at the moment leaves the stock 18.51% off its SMA200. HIMS registered 100.71% gain for a year compared to 6-month gain of 74.73%. The firm has a 50-day simple moving average (SMA 50) of $39.3308 and a 200-day simple moving average (SMA200) of $26.19965.
The stock witnessed a -23.67% loss in the last 1 month and extending the period to 3 months gives it a 16.91%, and is -16.17% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.45% over the week and 10.58% over the month.
Hims & Hers Health Inc (HIMS) has around 1637 employees, a market worth around $6.90B and $1.48B in sales. Current P/E ratio is 58.06 and Fwd P/E is 36.11. Profit margin for the company is 8.54%. Distance from 52-week low is 177.23% and -57.45% from its 52-week high. The company has generated returns on investments over the last 12 months (25.92%).
The EPS is expected to grow by 12.77% this year.
Hims & Hers Health Inc (HIMS) Top Institutional Holders
535.0 institutions hold shares in Hims & Hers Health Inc (HIMS), with institutional investors hold 89.02% of the company’s shares. The shares outstanding are 212.46M, and float is at 181.99M with Short Float at 30.07%. Institutions hold 78.99% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 16.47 million shares valued at $332.55 million. The investor’s holdings represent 7.7166% of the HIMS Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 14.57 million shares valued at $294.25 million to account for 6.7907 of the shares outstanding. The other top investors are RENAISSANCE TECHNOLOGIES LLC which holds 6.04 million shares representing 2.8294% and valued at over $121.94 million, while holds 2.4507 of the shares totaling 5.26 million with a market value of $106.19 million.
Hims & Hers Health Inc (HIMS) Insider Activity
The most recent transaction is an insider sale by Boughton Soleil, the company’s Chief Legal Officer. SEC filings show that Boughton Soleil sold 3,236 shares of the company’s common stock on Mar 31 ’25 at a price of $27.77 per share for a total of $89864.0. Following the sale, the insider now owns 0.17 million shares.
Still, SEC filings show that on Mar 26 ’25, Baird Melissa (Chief Operating Officer) disposed off 67,687 shares at an average price of $34.84 for $2.36 million. The insider now directly holds 751,243 shares of Hims & Hers Health Inc (HIMS).
